Evidence of recombination in quasispecies populations of a Hepatitis C virus patient undergoing anti-viral therapy

Virology Journal

Volumn 3, Issue , 2006, Pages

  Moreno, María P ^a   Casane, Didier ^b   López, Lilia ^a   Cristina, Juan ^a  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTIVIRUS AGENT; RIBAVIRIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; GENETIC RECOMBINATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; TREATMENT RESPONSE; UNINDEXED SEQUENCE; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; EVOLUTION, MOLECULAR; GENETIC VARIATION; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; PHYLOGENY; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC; RIBAVIRIN; SEQUENCE ALIGNMENT; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 33750828434     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-3-87     Document Type: Article

References (37)

1. Simmonds P: Genetic diversity and evolution of hepatitis C virus 15 years on. J Gen Virol 2004, 85:3173-3188.
2. Hoofnagle JH: Course and outcome of hepatitis C. Hepatology 2003, 36:S21-S29.
3. Pawlotsky JM: The nature of interferon-alfa resistance in hepatitis C virus infection. Curr Opin Infect Dis 2003, 16:587-592.
4. Chambers TJ, Fan X, Droll DA, Hembrador E, Slater T, Nickells MW, Dustin LB, Dibisceglie AM: Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection. J Virol 2005, 79:3071-3083.
5. Laskus T, Wilkinson J, Gallegos-Orozco JF, Radkowski M, Adair DM, Nowicki M, Operskalsi E, Buskell Z, Seeff LB, Vargas H, Rakela J: Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion. Gastroenterology 2004, 127:764-776.
6. Feliu A, Gay E, Garcia-Retortillo M, Saiz JC, Foms X: Evolution of hepatitis C virus quasispecies immediately following liver transplantation. Liver Transpl 2004, 10:1131-1139.
7. Martell M, Esteban JL, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J: Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992, 66:3225-3229.
8. You S, Stump DD, Branch AD, Rice CM: A cis-actingreplication element in the sequence encoding the NS5B RNA-dependent RNA polymerase is required for hepatitis C virus RNA replication. J Virol 2004, 78:1352-1366.
9. Pestova TV, Shatsky IN, Fletcher SP, Jackson RJ, Hellen CUT: A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binging to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev 1998, 12:6783.
10. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin IT, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A: Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hematology 2005, 42:962-973.
11. Simmonds P: The origin and evolution of hepatitis viruses in humans. J Gen Virol 2001, 82:693-712.
12. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS: Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993, 74:2391-2399.
13. Zeuzem S: Heterogenous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well? Ann Intern Med 2004, 140:370-381.
14. Fried MW, Hadziyannis SJ: Treatment of chronic hepatitis C infection with peginterferons plus ribavirin. Semin Liver Dis 2004, 24:47-54.
15. Kew OM, Nottay BK: Evolution of the oral polio vaccine strains in humans occurs by both mutation and intra-molecular recombination. In Modern Approaches to Vaccines Edited by: Chanock RM, Lerner RA. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1984:357-363.
16. Worobey M, Holmes EC: Evolutionary aspects of recombination in RNA viruses. J Gen Virol 1999, 80:2535-2543.
17. Suzuki Y, Gojobori T, Nakagomi O: Intragenic recombinations in rotaviruses. FEBS Lett 1998, 427:183-187.
18. Kalinina O, Norder H, Magnius O: Full-length open reading frame of a recombinant hepatitis C virus strain from St. Petersburg: proposed mechanism of its formation. J Gen Virol 2004, 85:1853-1857.
19. Kalinina O, Norder H, Mukomolov S, Magnius LO: A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 2002, 76:4034-4043.
20. Colina R, Casane D, Vasquez S, Garcia-Aguirre L, Chunga A, Romero H, Khan B, Cristina J: Evidence of intratypic recombination in natural populations of hepatitis C virus. J Gen Virol 2004, 85:31-37.
21. Cristina J, Colina R: Evidence of structural genomic region recombination in Hepatitis C virus. Virology J 2006, 3:53-56.
22. Puig-Basagoiti F, Forns X, Furcic I, Ampurdanes S, Gimenez-Barcons M, Franco S, Sanchez-Tapias JM, Saiz JC: Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chonic hepatitis C. J Gen Virol 2005, 86:1067-1075.
23. Kuiken C, Yusim K, Boykin L, Richardon R: The HCV Sequence Database. Bioinformatics 2005, 21:379-384.
24. Lole KS, Bollinger RC, Parnjape RS, Gadkari D, Kulkarni SS: Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999, 73:152-160.
25. Salminen MO, Carr JK, Burke DS, McCutchan FE: Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 1995, 11:1423-1425.
26. Holmes EC, Worobey M, Rambaut A: Phylogenetic evidence for recombination in dengue virus. Mol Biol Evol 1999, 16:405-406.
27. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C: Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A gene. J Clin Investig 1995, 96:224-230.
28. Gimenez-Barcons M, Franco S, Suarez Y, Forns X, Ampurdanes S, Puig-Basagoiti F, Sanchez-Fueyo A, Barrera JM, Llovet JM, Bruix J, Sanchez-Tapias JM, Rodes J, Saiz JC: High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis. Hepatology 2001, 34:158-167.
29. Witherell GW, Beineke P: Statistical analysis of combined substitutions in non-structural 5A region of hepatitis C virus and interferon response. J Med Virol 2001, 63:8-16.
30. Domingo E, Holland JJ: RNA virus mutations and fitness for survival. Annu Rev Microbiol 1997, 51:151-178.
31. Gale MJ, Korth MJ, Tang NM, Tan SL, Hopkins DA, Dever TE, Polyak SJ, Gretch DR, Katze MG: Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 1997, 230:217-227.
32. Gale MJ, Blakely CM, Kwieciszewski B, Tan SL, Dossett M, Tang NM, Korth MJ, Polyak SJ, Gretch DR, Katze MG: Control of PKR protein kinase by Hepatitis C Virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cel Biol 1998, 18:5208-5218.
33. Pawlotsky JM, Germanidis G, Neumann AU, Pellerin M, Frainais PO, Dhumeaux D: Interferon Resistance of Hepatitis C Virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations. J Virol 1998, 72:2795-2805.
34. Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acid Res 1994, 22:4673-4680.
35. Rambaut A, Grassly NC: Seq-Gen: an application for the Monte Carlo simulation of DNA sequence evolution along phylogenetic trees. Comp Appl Biosci 1997, 13:235-238.
36. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Maruno F, Sato C: Mutations in the non-structural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996, 344:77-81.
37. Pawlotsky JM, Germanidis G, Neumann AU, Pellerin M, Frainais PO, Dhumeaux D: Interferon Resistance of Hepatitis C Virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations. J Virol 1998, 72:2795-2805.